ALBEMARLE CORP reported the first quarter ended March 31, 2026 results: revenue $1.4 billion, net income $319 million, EPS $2.34 per diluted share.
“quarter ended March 31, 2026. First Quarter 2026 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) • Net sales of $1.4 billion, up 33% due to higher volumes and pricing in Energy Storage (volumes +14%, price +51%) and Specialties (volumes +7%, price +2%). • Net income of $319 million, or $2.34 per”
Material Agreements
ALBEMARLE CORP amended Third Amendment with Bank of America, N.A. (effective 2026-03-19).
“On March 19, 2026, Albemarle Corporation (the “Company”), Albemarle Europe Srl, the lenders party thereto and Bank of America, N.A., as administrative agent, entered into the third amendment (the “Third Amendment”) to that certain amended and restated credit agreement dated as of October 28, 2022”
M&A Transactions
ALBEMARLE CORP completed a disposition involving ChemCat AcquisitionCo, LLC for approximately $547 million in cash (closed 2026-03-02).
“arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,”
John C. Barichivich III departed as principal accounting officer at ALBEMARLE CORP.
“As previously announced, John C. Barichivich III will cease serving as the Company’s principal accounting officer upon the effective date of Mr. LaBauve’s appointment as his successor.”
Donald J. LaBauve, Jr. was appointed as Chief Accounting Officer at ALBEMARLE CORP.
“On October 28, 2024, Albemarle Corporation (the “Company”) appointed Donald J. LaBauve, Jr. (Jim) as the Company’s Chief Accounting Officer, effective November 11, 2024.”
John C. Barichivich III departed as Vice President, Corporate Controller and Chief Accounting Officer at ALBEMARLE CORP.
“In addition, in connection with the implementation of such new operating structure, John C. Barichivich III will cease serving as Vice President, Corporate Controller and Chief Accounting Officer of the Company effective upon the appointment of his successor, and his last day of employment will be December 31, 2024.”
Kristin Coleman departed as Executive Vice President, General Counsel and Corporate Secretary at ALBEMARLE CORP.
“On October 7, 2024, in connection with the implementation of the new operating structure described in Item 7.01 below, Kristin Coleman will cease serving as Executive Vice President, General Counsel and Corporate Secretary of Albemarle Corporation (the “Company”), and her last day of employment will be November 4, 2024.”
Governance Changes
ALBEMARLE CORP: Increased authorized common shares from 150,000,000 to 275,000,000 (effective 2024-05-10).
“Albemarle Corporation (the “Company”) filed Articles of Amendment with the State Corporation Commission of the Commonwealth of Virginia (the “SCC”) to amend the Company’s Amended and Restated Articles of Incorporation (the “Charter”) to increase the number of authorized shares of common stock, $0.01 par value per share, from 150,000,000 to 275,000,000 (the “Charter Amendment”).”
Shareholder Votes
ALBEMARLE CORP shareholders approved Ratification of appointment of independent registered public accounting firm at the 2024-05-07 meeting.
“Proposal 4 . Ratification of appointment of independent registered public accounting firm . The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 86,248,537 7,754,186 439,695 N/A”
Shareholder Votes
ALBEMARLE CORP shareholders approved Charter Amendment to increase the number of authorized shares of common stock at the 2024-05-07 meeting.
“Proposal 3 . Charter Amendment to increase the number of authorized shares of common stock . The shareholders approved the Charter Amendment to increase the Company’s number of authorized shares of common stock by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 88,786,666 5,369,507 286,245 N/A”
Shareholder Votes
ALBEMARLE CORP shareholders approved Advisory vote on executive compensation at the 2024-05-07 meeting.
“Proposal 2 . Advisory vote on executive compensation . The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, as set forth in the Proxy Statement, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 67,682,378 11,136,388 1,705,771 13,917,881”
Shareholder Votes
ALBEMARLE CORP shareholders approved Election of directors at the 2024-05-07 meeting.
“Proposal 1 . Election of directors . The shareholders elected all of the nominees for director to serve for a term expiring at the annual meeting of shareholders in 2025 by the votes set forth in the table below.”
Earnings Releases
ALBEMARLE CORP reported the first quarter ended March 31, 2024 results: revenue $1.4 billion, net income $2 million, or ($0.08) per diluted share attributable to common shareholders. Guidance reaffirmed.
“today announced its results for the first quarter ended March 31, 2024. First-Quarter 2024 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) • Net sales of $1.4 billion, driven by Energy Storage volume growth as projects ramp • Net income of $2 million, or ($0.08) (a) per diluted share attributable to common shareholders”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.